/People

Conrad Wang

Director at Eyconis · Board director at Alpheus Medical · Board director at Access Closure · Former Partner at HealthQuest Capital

New York, New York

Writes $1M – $75M checks · typically $4M

Find your path to Conrad

197 people in our graph can introduce you to Conrad.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Louis Berneman to introduce you to Conrad

You →Louis · together at HEALTHCARE ROYALTY PARTNERS (2015–2019) →Conrad

Ask Jamie Chen to introduce you to Conrad

You →Jamie · 2 people · together at HEALTHCARE ROYALTY PARTNERS →Conrad

Ask Sam Okafor to introduce you to Conrad

You →Sam · together at Alpheus Medical →Conrad

Sign up to find every way you can get introduced to Conrad

  • Your email: the people you already email who know Conrad
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Conrad
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Conrad Wang is a Partner and Head of Drug Royalty Finance at SLR Capital Partners, focusing on healthcare and life sciences financing. His experience spans structured credit, private equity, venture capital, and growth equity investments across biotechnology, biopharmaceuticals, and medical devices. Wang has worked on transactions involving FDA regulatory pathways and serves in business development and M&A capacities within the healthcare sector.

Director at Eyconis

Intro paths

→

In turn, Conrad can intro founders to Eyconis's investors below.

Board director at Alpheus Medical

Intro paths

→

In turn, Conrad can intro founders to Alpheus Medical's investors below.

Board director at Access Closure

Co-founders at Access Closure

FK
Farhad KhosraviDirector

Experience

  1. SLR Capital PartnersPartner, Head of Drug Royalty Financecurrent2026 — presentNew York, New York, United States
  2. Alpheus Medical, IncBoard Member2025 — 2026
  3. Cellipont BioservicesBoard Member2024 — 2026
  4. Care ConnectorsBoard Member2024 — 2026
  5. HealthQuest CapitalPartner2023 — 2026United States
  6. Eyconis, IncBoard Member2023 — 2025
  7. OrbiMedPrincipal2019 — 2022Greater New York City Area
  8. AcufocusBoard Member2016 — 2019
  9. HealthCare Royalty PartnersPrincipal2015 — 2019
  10. TearscienceBoard Member2016 — 2017
  11. MedtronicSenior Director Corporate Development2013 — 2015Minneapolis
  12. Three Arch PartnersPrincipal2004 — 2013
  13. AccessClosureBoard member2010 — 2013Mountain View, CA
  14. Habit ManagementBoard member2010 — 2013
  15. Harvard Combined Orthopedic Residency ProgramOrthopedic Surgery Resident1999 — 2003

Skills & more

Royalty financingHealthcarePrivate EquityVenture CapitalMedical DevicesHealthcare Information TechnologyLife SciencesBiopharmaceuticalsBiotechnologyCommercializationStructured FinanceRoyalties
+12 moreStart-upsSurgeryClinical TrialsDue DiligenceClinical DevelopmentStrategyHospitalsFDAISO 13485Clinical ResearchClinicalBiomedical Engineering

Languages Chinese (Mandarin)

From Conrad's professional profile.

Frequently asked questions

Who is Conrad Wang?
Conrad Wang is a Partner and Head of Drug Royalty Finance at SLR Capital Partners, focusing on healthcare and life sciences financing. His experience spans structured credit, private equity, venture capital, and growth equity investments across biotechnology, biopharmaceuticals, and medical devices. Wang has worked on transactions involving FDA regulatory pathways and serves in business development and M&A capacities within the healthcare sector.
Where does Conrad Wang work?
Conrad Wang is Board director at Alpheus Medical and Board director at Access Closure.
What check size does Conrad Wang write?
Conrad Wang typically writes checks of $1M – $75M.
Where did Conrad Wang go to school?
Conrad Wang studied at Harvard Business School (MBA); Harvard Medical School (MD); Massachusetts Institute of Technology (SB, Mechanical Engineering).

Same school

Shared employers